Burden of Hospitalization for Coccidioidal Meningitis: An Analysis of the National Inpatient Sample, 2019–2021
2024

Burden of Hospitalization for Coccidioidal Meningitis

Sample size: 2305 publication Evidence: moderate

Author Information

Author(s): Coleman Craig I, Donovan Fariba, Miriyapalli Lahar, Shan Ryan, Lovelace Belinda

Primary Institution: University of Connecticut, University of Arizona

Hypothesis

This study aimed to assess the hospital burden associated with coccidioidal meningitis (CM), including inpatient mortality, healthcare utilization, and total hospital costs.

Conclusion

Coccidioidal meningitis inflicts a substantial burden on hospital resources, with high hospitalization costs and significant mortality rates.

Supporting Evidence

  • CM hospitalizations were associated with frequent CM-related procedures in 63.6% of cases.
  • The mean length of stay for CM hospitalizations was 13.0 days.
  • The mean total hospital treatment cost for CM was $48,155.
  • 7.6% of hospitalizations for CM resulted in death prior to discharge.

Takeaway

Coccidioidal meningitis is a serious illness that often requires long hospital stays and can be very expensive to treat.

Methodology

This retrospective, observational cohort study used the National Inpatient Sample from 2019 to 2021 to analyze hospitalizations for coccidioidal meningitis.

Potential Biases

Potential for sampling bias due to the retrospective nature of the study and reliance on ICD-10 coding.

Limitations

The study may have misclassification due to coding errors and does not provide data on medication use or outpatient treatment.

Participant Demographics

The mean age of patients was 47.9 years, predominantly male (73.3%), with a majority being White (31.5%) or Hispanic (37.2%).

Statistical Information

Confidence Interval

95% CI for various outcomes reported.

Digital Object Identifier (DOI)

10.1093/ofid/ofae706

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication